Innate Pharma Cash Flow Statement (2018-2025) | IPHA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Operating Activities
Net Income (Quarter) -23.62M23.52M-72.81M53.98M-60.09M-0.08M-66.12M-2.65M-8.61M56.36M-56.30M-24.29M-55.96M
Cash from Discontinued Operations (Quarter) -66.03M-58.91M-35.46M-66.52M-21.80M-13.05M-37.05M-7.85M-60.03M
Gains from Investment Securities (Quarter) -1.19M-1.13M
Change in Working Capital (Quarter) -0.36M0.63M-0.42M-0.29M-1.68M-1.35M-0.06M0.02M0.01M0.03M-0.00M
Other Working Capital Changes (Quarter) -0.55M-1.10M-0.33M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 64.63M5.23M51.67M5.79M2.27M1.57M
Investing Activities
Capital Expenditures (Quarter) -0.84M-1.45M-0.06M-1.03M-0.07M-1.06M-0.00M-0.61M-0.00M-0.40M0.32M-0.44M-0.16M
Sales of Property, Plant and Equipment (Quarter) -0.01M0.01M-0.00M0.53M0.02M0.03M
Change in Intangibles (Quarter) -72.98M-72.98M-10.59M-11.81M-0.04M-0.46M-0.67M-2.28M
Divestments (Quarter) -70.32M-70.69M-13.78M-15.21M-0.28M-1.04M-0.45M2.14M-0.28M23.48M10.47M8.29M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter) -0.83M-2.26M-1.17M-2.55M-1.28M-2.35M-1.09M-2.31M-1.81M-2.69M-5.03M-10.17M-10.14M
Misc.
Cash from Financing Activities (Quarter) -0.88M-1.36M-1.34M-1.40M-1.09M-2.08M-1.42M-2.24M-4.92M-6.84M
Exchange Rate Effect (Quarter) 173.33M-0.00M230.88M-0.01M-0.20M-0.55M-0.76M-0.49M-0.29M-0.57M
Change in Cash (Quarter) -3.34M-81.19M-75.21M-37.34M-37.59M-0.92M-22.23M-14.58M-15.50M-0.70M-4.79M-43.59M
Beginning Cash Balance (Quarter) 230.88M155.66M118.07M95.84M80.35M75.56M
Free Cash Flow (Quarter) 0.84M1.45M0.06M1.03M0.07M1.06M0.00M0.61M0.00M0.40M-0.32M0.44M0.16M
Net Cash Flow (Quarter) -0.88M-1.36M-1.34M-1.40M-1.09M-2.08M-1.42M-2.24M-4.92M-6.84M